Author: Kawira Mutisya

Yvonne Kawira is an award winning journalist with an interest in matters, regional trade, tourism, entrepreneurship and aviation. She has been practicing for six years and has a degree in mass communication from St Paul’s University.

Pfizer vaccines from the United States

The Africa Centres for Disease Control and Prevention, Africa CDC, has issued a statement on the recent international travel rules in the context of the COVID-19 pandemic. The Specialised Technical Institution of the African Union, noted in a statement that the planned changes to international travel rules are discrminative. The rules  were communicated by the Government of the United Kingdom (U.K), which will be enforced starting at 4:00 am on Monday 4th October 2021. Also Read: Public, private sector investment needed for vaccine manufacturing: EAC “With a full course of the Oxford/AstraZeneca, Pfizer BioNTech, Moderna or Janssen vaccines from a relevant public…

Read More

A recent report by Save the children has revealed that Kenyan children born over the past year will on average face 4.6 times more drought during their lives than their grandparents. According to the research, the risk is significantly higher in many low- and middle-income countries, particularly in Asia and Africa. Compared to 60-year-olds, newborns in Afghanistan will confront 5.3 times more drought in their lifetimes. “In Tanzania and Kenya, children will face 2.8 and 4.6 times the exposure to drought, respectively,” it read in part. The organisation also noted that the children will be the most affected because they…

Read More

Currently, Dr Onyino says that the Kenya Medical Association is a member of the NHIF Board where we have contributed to the reform agenda aimed at optimizing the organization in readiness to implement UHC.

The current proposed National Hospital Insurance Fund (Amendment) Bill, 2021, which leaves the KMA unrepresented on the Board of NHIF, will silence the voices of professional doctors in shaping UHC, which must strike a balance between financial sustainability and providing proper medical services to Kenyans, consistent with the oath we have sworn.

Read More

In Kenya, more than 12,000 people have end-stage kidney disease requiring dialysis. Currently, more than 5,000 patients are on dialysis in Kenya. This is according to data provided by the ministry of health. There are currently  214 dialysis units countrywide in our public (54), private (143) as well as faith-based (17) health facilities. According to the Chief Administrative Secretary Ministry of Health Dro Mercy Mwangangi, what is astonishing is there are only 41 nephrologists and 560 nurses in the country to deal with all these patients. All is not doom Dr Mwangangi says that there have been success stories that…

Read More

In the past decade, Kenya has made tremendous advancements in increasing access to modern methods of contraception. However, this has significantly reduced in the past year and experts are linking this downward trajectory to the recent global pandemic. “In Kenya, contraceptives use among women of reproductive health has been on an upward trajectory from 37.2 percent in 2017/18 to 44 percent in 2019/2020. This rate has declined to 29.6% in 2020/21, due to disruption caused by the Covid-19 pandemic.(KHIS, 2021),” said Dr. Patrick Amoth the chairperson of the World Health Organisation (WHO) executive board. Data from the Ministry of Health…

Read More

According to data availed by the ministry of health, Dolutegravir (DTG) based regimens have high potency, a high genetic barrier to HIV drug resistance, low toxicity, and have fewer drug-to-drug interactions. 

It says that the availability of DTG 50mg film-coated tablets will foster improved adherence among the Children and Adolescents Living with HIV thereby improving treatment outcomes in children and adolescents.

“Evidence supports using DTG as a preferred First line ARV drug for Children and adolescents living with HIV with approved dosing and people co-infected with TB. The donation today adds an impetus to ensure that no child or adolescent living with HIV and has been transitioned to DTG as their current regimen, misses their drugs,” she added.

Read More

For the first time, Pfizer vaccines from the United States have landed in the country. The country received 795,600 doses of the expected 1.4 million doses of Pfizer vaccine provided by the US Government. Due to the nature of the Pfizer vaccines, they can only survive in extremely low temperatures which is minus 70 degrees. The government thus had to make prior arrangements with its partners to acquire ultra-cold storage and install it to maintain the quality of the vaccines. To enable the use of Pfizer vaccines in Kenya, United Nations Children’s Fund (UNICEF) has recently procured 12 ultra-low temperature…

Read More

The Kenya Private Sector Alliance (KEPSA) has reaffirmed its commitment to the governments effort in combating the deadly COVID-19 pandemic. In a statement to newsrooms, KEPSA noted that it has been at the forefront in coordinating the private sector response and complementing the government’s efforts towards combating the effects of the Covid-19 pandemic on the economy, general health, and social wellbeing of Kenyans. “We would like to affirm the government’s position, reiterated by the Health Cabinet Secretary Mr Mutahi Kagwe on private sector’s partnership through KEPSA on the vaccine initiative. We have partnered with the government through the Ministry of…

Read More

Kenya has become the first country in Africa, and globally, to launch a national malaria youth army.   In the global arena, it has been a constant battle to eradicate malaria and efforts have been channeled towards this initiative.  Below is a global map and the malaria prevalence in each country.  Countries with zero indigenous cases over at least the past three consecutive years are considered to have eliminated malaria.   In 2019, China and El Salvador reported zero indigenous cases for the third consecutive year and have applied for World Health Organisation (WHO) certification of malaria elimination; also, Iran, Malaysia and Timor Leste reported zero indigenous cases…

Read More

Kenya and Uganda are among the countries selected for the Phase 1 clinical trial of an HIV vaccine.  According to the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT), the first dose will be given in Lusaka, Zambia while Kenya and Uganda will receive the vaccines in a few weeks.   Dr. William Kilembe, project director of the Center for Family Health Research in Zambia (CFHRZ) and trial principal investigator, said that international partnerships are crucial in developing and evaluating HIV vaccine candidates in countries and communities where HIV vaccines will ultimately have the greatest public health impact.  “CFHRZ is proud to be part of the…

Read More